• Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

  • Jan 30 2025
  • Length: 19 mins
  • Podcast

Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Listen for free

View show details

  • Summary

  • Quantum BioPharma is developing a portfolio of products including Quantum's Lucid-MS drug development and their drink, unbuzzd. In this episode, Adam Torres and Jason Sawyer, Head of Finance & M&A at Quantum BioPharma, explore Quantum BioPharma. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show more Show less
Show more Show less

What listeners say about Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available